BTOG
LightNews LightNews
banner
btog.bsky.social
BTOG
@btog.bsky.social
180 followers 58 following 200 posts
British Thoracic Oncology Group (BTOG) - multi-disciplinary group for professionals involved with thoracic malignancies.
Posts Replies Media Videos
btog.bsky.social
📢 Registration is open for the 24th BTOG Annual Conference!
Join us in Edinburgh, 4–6 March 2026, for cutting-edge science, debate and collaboration across thoracic oncology.
🔗 https://www.btog.org/24th-btog-annual-conference-2026/

#BTOG26 #LCSM #lungcancer
January 5, 2026 at 8:50 AM
btog.bsky.social
BTOG wishes to inform members of a new NICE release that has been published today.

www.btog.org/amivantamab-...

#LCSM
December 18, 2025 at 10:42 AM
btog.bsky.social
BTOG is pleased to highlight a new practical guide published in Clinical Oncology for providing post-operative radiotherapy to thymic epithelial tumours developed by our Thymic Malignancies Special Interest Group.

www.btog.org/new-cli...
December 12, 2025 at 9:00 AM
btog.bsky.social
Our latest podcast is with @uklungcancer.bsky.social and discusses their recent conference looking at what's next. With @tnewsomdavis.bsky.social Emma O'Dowd David Gilligan. #LCSM #LungCancer
Listen on Apple Podcasts, Spotify or Amazon Music (search 'BTOG') or our website www.btog.org/btog-podcasts/
December 10, 2025 at 1:54 PM
btog.bsky.social
Innovation drives progress. From clinical research to education, BTOG supports the lung cancer community in delivering better treatments and outcomes.
#LungCancerAwareness #LCSM #LungCancer
November 17, 2025 at 10:00 AM
btog.bsky.social
BTOG is excited to share the 1st Release Draft Programme for #BTOG26 (subject to faculty confirmations). #LCSM

btog.org/24th-btog-an...
November 12, 2025 at 12:38 PM
Reposted by BTOG
oncogenecancer.bsky.social
Research isn’t separate from care - it is care.

As Professor @drsanjaypopat.bsky.social reminds us, advancing #lungcancer research is how we deliver the best possible treatment, outcomes & hope.

Support research. Share stories. Drive change.

#StoriesOfLungCancer #LCAM25 @btog.bsky.social
Photo of Professor Sanjay Popat saying "Research is fundamental to providing state-of-the-art care." All about supporting life saving lung cancer research during LCAM.
November 3, 2025 at 12:12 PM
btog.bsky.social
Early detection saves lives. Screening, research and collaboration are key to tackling lung cancer. BTOG is committed to advancing knowledge and improving care across the UK.
#LungCancerAwareness #LCSM #LungCancer
November 10, 2025 at 9:00 AM
btog.bsky.social
⏳ 1 week to go!
We’re nearly there — a full day on non-smoking lung cancer: from diagnosis to survivorship. With @ruthstraussfdn.bsky.social
Still time to register 👉
🔗 www.btog.org/non-smo...
📅 Thurs 13 Nov | 📍 London
#LungCancer #LCSM #NonSmokingLungCancer
November 6, 2025 at 10:00 AM
btog.bsky.social
Just out: ESMO Top 10 Abstracts Webcast & Podcast

The rationale and design, efficacy, side effects & potential impact with: @tnewsomdavis.bsky.social Dr Shobhit Baijal & Dr Sharmistha Ghosh.

Video webcast is members only, audio podcast open access.

Details: www.btog.org/esmo25-top10-webcast/
November 5, 2025 at 12:21 PM
btog.bsky.social
💭 What’s in a name?
Martin Forster opens the event exploring how we label non-smoking lung cancer — and why it matters.
📅 Join us 13 Nov, London
🔗 www.btog.org/non-smo...

#Oncology #LungCancer
October 30, 2025 at 10:00 AM
btog.bsky.social
New #podcast release:

BTOG does … Chemo RT: What to do in unresectable disease

Dr Emma O'Dowd talks to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.

Search BTOG in App Store/Spotify/Amazon Music or listen via BTOG website www.btog.org/btog-po...

#LCSM
October 29, 2025 at 1:00 PM
btog.bsky.social
✅ CPD credits (applied for)
✅ Patient voice
✅ Groundbreaking science
🎟️ Join the BTOG Non-Smoking Lung Cancer Essential Update with @ruthstraussfdn.bsky.social
📅 13 Nov, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 23, 2025 at 9:00 AM
btog.bsky.social
BTOG wishes to inform members of a new @nicecomms.bsky.social release published today.

NICE has recommended Lorlatinib as an option for ALK-positive advanced non-small-cell lung cancer in adults who have not had an ALK inhibitor.

More details
www.nice.org.uk/guidance/TA1...

#LCSM #LungCancer
Overview | Lorlatinib for ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor | Guidance | NICE
www.nice.org.uk
October 21, 2025 at 12:25 PM
btog.bsky.social
👥 Meet the experts:
🧑‍⚕️ @tnewsomdavis.bsky.social
🧑‍⚕️ Martin Forster
and many more with @ruthstraussfdn.bsky.social at #NonSmokingLungCancer.
A full day of learning and networking awaits.
📆 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 16, 2025 at 9:00 AM
btog.bsky.social
Screening Event
🎉 Today’s the day!
The #BTOGScreeningEvent kicks off in London with vital updates on #LungCancer screening across the UK.
We’ll be talking strategy, challenges, and the future of screening.
Follow along and join the conversation ⬇️ #BTOGScreeningEvent
#LCSM
October 14, 2025 at 6:00 AM
Reposted by BTOG
nlca-natcan.bsky.social
The October NLCA newsletter is out now! Read about our QI intervention, upcoming State of the Nation report and more…!
www.natcan.org.uk/news/nlca-ne...

@hqip.bsky.social @btog.bsky.social
#LungCancer
NLCA Newsletter, October 2025 - National Cancer Audit Collaborating Centre
We use some essential cookies to make this website work.
www.natcan.org.uk
October 6, 2025 at 8:53 AM
Reposted by BTOG
nlca-natcan.bsky.social
The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024:
rcs-ceu.shinyapps.io/NLCA/

@hqip.bsky.social @btog.bsky.social #LungCancer
rcs-ceu.shinyapps.io
October 9, 2025 at 9:30 AM
btog.bsky.social
We’re ready. Are you?
👥 Meet national experts
🧠 Debate real-world screening issues
🗣️ Submit your questions live
📍London | ⏰ Doors open 08:30
See you tomorrow at the #BTOGScreeningEvent
#LungCancer #LCSM
October 13, 2025 at 9:00 AM
btog.bsky.social
💡 Discover the latest in mutation-driven lung cancer research.
Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 9, 2025 at 9:00 AM
btog.bsky.social
1 week to go!
⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges.
Don’t miss it — register today: www.btog.org/btog-sc...
#LungCancer #LCSM
October 7, 2025 at 9:00 AM
btog.bsky.social
"🧩 Local Consolidative Therapy – survival benefits or overtreatment?
Hear from experts tackling difficult questions in non-smoking lung cancer.
🎫 Register today
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
With @RuthStraussFdn"
October 2, 2025 at 9:47 AM
btog.bsky.social
Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh.

Full details are on the website www.btog.org/24th-btog-an...

#LCSM #lungcancer
October 1, 2025 at 11:31 AM
Reposted by BTOG
allyouneedislungs.bsky.social
Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁

🗓️ Apply by 10 Jan 2026 #LCSM

ruthstraussfoundation.com/grants-progr...
September 29, 2025 at 5:26 PM
Reposted by BTOG
iaslc.bsky.social
♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25.

🔗 Read more in ILCN: bit.ly/46m612v
Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC - ILCN.org (ILCN/WCLC)
Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.
bit.ly
September 29, 2025 at 2:32 PM